Norwegian Institute of Public Health
Oslo, Norway
NCT Number: NCT05642754
Randomized trial testing 6 forms of a communication summarizing the results of a recent study (about the effects of wearing glasses on reducing covid infection risk).
The goal of the trial is to test the effect of different language options to describe uncertainty, and of including the margin of error around the main result.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Oslo, Norway
The study is designed as a proof-of-concept exercise to develop and test a communication meant to summarize the results of a recent randomized trial examining the effects of wearing glasses on the chance of developing COVID-19.
The objectives of the randomized trial are:
Researchers will conduct an online, parallel group, individually randomized, pragmatic trial using a 3x2 factorial design, ie, 3 uncertainly language options (GRADE language, colloquial language or none 2 options for the statistical margin of error for the main results (margin of error language or none).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Researchers are testing different forms of information about overall study uncertainty and margin of error around main result
Other names: Margin of error around main result
Time frame: within 1 day
How sure about the effect (4 point scale from very unsure to very sure)
Time frame: within 1 day
How sure about the effect (4 point scale from very unsure to very sure)
Time frame: within 1 day
How sure about the effect (4 point Likert scale)
Time frame: within 1 day
this is a co-primary outcome which will be used only to compare the 3 versions that include the margin of error to the 3 versions that do not
Time frame: within 1 day
What is the effect on a 5 point scale (lowers a lot, lowers a little, no effect, increase a little, increases a lot
Time frame: within 1 day
4 point scale (very likely, likely, unlikely, very unlikely)
Time frame: within 1 day
4 point scale (very likely, likely, unlikely, very unlikely
Time frame: within 1 day
4 point scale (very likely, likely, unlikely, very unlikely
Time frame: within 1 day
4 point Likert scale (strongly agree, agree, disagree, strongly disagree)
Time frame: within 1 day
4 point Likert scale (strongly agree, agree, disagree, strongly disagree)
Time frame: within 1 day
4 point scale (very clear, clear, unclear, very unclear)
Time frame: within 1 day
4 point scale (very clear, clear, unclear, very unclear)
Time frame: within 1 day
4 point scale (very helpful, helpful, unhelpful, very unhelpful)
Time frame: within 1 day
4 point scale (definitely yes, probably yes, probably no, definitely no)
Time frame: within 1 day
4 point LIkert scale (strongly agree, agree, disagree, strongly disagree)
Time frame: within 1 day
4 point LIkert scale (strongly agree, agree, disagree, strongly disagree)
Time frame: within 1 day
4 point LIkert scale (strongly agree, agree, disagree, strongly disagree)
Trustees of Dartmouth College
Other
Communicating Uncertainty About the Effects of Wearing Glasses to Reduce the Chance of Getting COVID (Corona Virus Disease): Protocol for a Randomized Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04794829
COVID-19, Coronaviridae Infections
Bethesda, Maryland, United States
View Trial DetailsNCT07552779
COVID-19, COVID-19 (Coronavirus Disease 2019)
Brussels, Bruxelles-capitale, Région de, Belgium
View Trial DetailsNCT07722000
COVID-19, Chronic Disease
Banī Suwayf, Beni Suweif Governorate, Egypt
View Trial DetailsNCT04371432
COVID-19, Coronaviridae Infections
Bethesda, Maryland, United States
View Trial Details